Contineum Therapeutics, Inc. Class A Common Stock vs. Johnson & Johnson
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
$8.56 -35.99%
VS JNJJohnson & Johnson
$263.73 +0.88%
Johnson & Johnson (JNJ) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| CTNM | JNJ | |
|---|---|---|
| Market Cap | $503.37 million | $630.04 billion |
JNJ leads on 1 of 1 size & scale factors.
Dividend
| CTNM | JNJ | |
|---|---|---|
| Dividend Yield | — | 2.03% |
CTNM and JNJ split the dividend factors evenly.
Risk & Sentiment
| CTNM | JNJ | |
|---|---|---|
| Short Interest | 1.59% | 0.67% |
JNJ leads on 1 of 1 risk & sentiment factors.
Dig deeper: CTNM overview, CTNM financials, JNJ overview, JNJ financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.